search
Back to results

Avoiding Hypotension in Preterm Neonates (AHIP)

Primary Purpose

Hypotension

Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
NIRS visible and predefined interventions
NIRS not visible and treatment as usual
Sponsored by
Medical University of Graz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypotension

Eligibility Criteria

undefined - 6 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • preterm neonates
  • decision to conduct full life support
  • written informed consent
  • age <6 hours
  • no use of catecholamines before start of NIRS measurements

Exclusion Criteria:

  • no decision to conduct full life support
  • no written informed consent
  • age >6 hours
  • use of catecholamines before start of NIRS measurements
  • congenital malformation

Sites / Locations

  • Dep. of Pediatrics, Medical University of Graz

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

NIRS visible and predefined interventions

NIRS not visible and treatment as usual

Arm Description

NIRS measurements are visible and the patients will be treated according to predefined clinical interventions: If cTOI/pTOI ratio increases >5% within a six-hours-period echocardiography will be performed and based on results of echocardiography and blood pressure a volume bolus or, if ventilated, modification of ventilation or treatment of patent ductus arteriosus will be considered.

NIRS measurements are not visible and the patients will be treated according to routine ('treatment as usual')

Outcomes

Primary Outcome Measures

Time (percentage of hours) of hypotension/use of catecholamines during the first 48 hours

Secondary Outcome Measures

Cerebral injury by cerebral ultrasound
From date of randomization until the date of discharge or date of 40 weeks of gestational age, whichever came first, assessed up to 16 weeks.
Mortality

Full Information

First Posted
July 19, 2013
Last Updated
January 16, 2017
Sponsor
Medical University of Graz
search

1. Study Identification

Unique Protocol Identification Number
NCT01910467
Brief Title
Avoiding Hypotension in Preterm Neonates
Acronym
AHIP
Official Title
Avoiding Hypotension in Preterm Neonates (AHIP) - A Randomised Controlled Study on Near Infrared Spectroscopy Monitoring of Peripheral-muscle and Cerebral Oxygenation With Defined Interventions Versus Routine Monitoring and Treatment in Preterm Neonates
Study Type
Interventional

2. Study Status

Record Verification Date
January 2017
Overall Recruitment Status
Completed
Study Start Date
November 2013 (undefined)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
December 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Graz

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Objectives Firstly to examine in preterm neonates, whether it is possible to reduce number of hypotensive episodes and use of catecholamines by applying cerebral/peripheral near infrared spectroscopy in combination with predefined interventions and secondly to explore the potential impact on cerebral injury and mortality. Hypothesis By using predefined interventions for changes in cerebral/peripheral oxygenation ratio investigators will reduce hypotensive episodes and use of catecholamines which will reduce cerebral injury and mortality. Methods Cerebral (cTOI) and peripheral-muscle (pTOI) tissue-oxygenation-index (NIRO 300) will be measured for 24h starting <6 hours postpartum. When cTOI/pTOI ratio increases >5% within a 6h period, predefined interventions will be performed. Primary outcome parameter will be duration of hypotensive episodes and use of catecholamines during the first 48h after birth. Secondary outcome parameters will be cerebral injury and mortality.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
98 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NIRS visible and predefined interventions
Arm Type
Experimental
Arm Description
NIRS measurements are visible and the patients will be treated according to predefined clinical interventions: If cTOI/pTOI ratio increases >5% within a six-hours-period echocardiography will be performed and based on results of echocardiography and blood pressure a volume bolus or, if ventilated, modification of ventilation or treatment of patent ductus arteriosus will be considered.
Arm Title
NIRS not visible and treatment as usual
Arm Type
Other
Arm Description
NIRS measurements are not visible and the patients will be treated according to routine ('treatment as usual')
Intervention Type
Device
Intervention Name(s)
NIRS visible and predefined interventions
Intervention Description
NIRS measurements are visible and the patients will be treated according to predefined clinical interventions: If cTOI/pTOI ratio increases >5% within a six-hours-period echocardiography will be performed and based on results of echocardiography and blood pressure a volume bolus or, if ventilated, modification of ventilation or treatment of patent ductus arteriosus will be considered.
Intervention Type
Device
Intervention Name(s)
NIRS not visible and treatment as usual
Intervention Description
NIRS not visible and the patients will be treated according to routine
Primary Outcome Measure Information:
Title
Time (percentage of hours) of hypotension/use of catecholamines during the first 48 hours
Time Frame
48 hours
Secondary Outcome Measure Information:
Title
Cerebral injury by cerebral ultrasound
Description
From date of randomization until the date of discharge or date of 40 weeks of gestational age, whichever came first, assessed up to 16 weeks.
Time Frame
up to 16 weeks
Title
Mortality
Time Frame
up to 16 weeks
Other Pre-specified Outcome Measures:
Title
Neonatal morbidities
Description
From date of randomization until the date of discharge or date of 40 weeks of gestational age, whichever came first, assessed up to 16 weeks.
Time Frame
up to 16 weeks
Title
Heart rate
Time Frame
48 hours
Title
Blood pressure
Time Frame
48 hours
Title
Arterial oxygen saturation
Time Frame
48 hours

10. Eligibility

Sex
All
Maximum Age & Unit of Time
6 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: preterm neonates decision to conduct full life support written informed consent age <6 hours no use of catecholamines before start of NIRS measurements Exclusion Criteria: no decision to conduct full life support no written informed consent age >6 hours use of catecholamines before start of NIRS measurements congenital malformation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gerhard Pichler, MD
Organizational Affiliation
Dep. of Pediatrics, Medical University of Graz
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dep. of Pediatrics, Medical University of Graz
City
Graz
State/Province
Styria
ZIP/Postal Code
8036
Country
Austria

12. IPD Sharing Statement

Citations:
PubMed Identifier
32692715
Citation
Hoeller N, Baik-Schneditz N, Schwaberger B, Mileder L, Urlesberger B, Pichler G. Cerebral and peripheral muscle oxygenation and perfusion: Course in moderate and late preterm neonates during the first day after birth. Physiol Int. 2020 Jul 17;107(2):267-279. doi: 10.1556/2060.2020.00028.
Results Reference
derived
PubMed Identifier
29450194
Citation
Pichler G, Holler N, Baik-Schneditz N, Schwaberger B, Mileder L, Stadler J, Avian A, Pansy J, Urlesberger B. Avoiding Arterial Hypotension in Preterm Neonates (AHIP)-A Single Center Randomised Controlled Study Investigating Simultaneous Near Infrared Spectroscopy Measurements of Cerebral and Peripheral Regional Tissue Oxygenation and Dedicated Interventions. Front Pediatr. 2018 Feb 1;6:15. doi: 10.3389/fped.2018.00015. eCollection 2018.
Results Reference
derived

Learn more about this trial

Avoiding Hypotension in Preterm Neonates

We'll reach out to this number within 24 hrs